Company Filing History:
Years Active: 2009
Title: Alison J. Wilton: Innovator in Human Antibody Development
Introduction: Alison J. Wilton, based in Cambridge, MA, is a distinguished inventor known for her contributions to biotechnology. With a focus on human antibodies, her work has significant implications in medical research and therapeutic applications.
Latest Patents: Alison holds a patent for "Human antibodies that bind human TNFα." This invention involves recombinant human antibodies that specifically bind to human tumor necrosis factor α (hTNFα). The antibodies exhibit high affinity for hTNFα and demonstrate a slow off rate, effectively neutralizing hTNFα activity both in vitro and in vivo. The patent includes methods for synthesizing these antibodies, including nucleic acids, vectors, and host cells for expression.
Career Highlights: Alison Wilton's career is marked by her dedication to advancing biopharmaceuticals. Her work at Abbott Biotechnology Ltd. reflects her commitment to developing innovative solutions for medical challenges.
Collaborations: Throughout her career, Alison has collaborated with esteemed colleagues such as Jochen G. Salfeld and Deborah J. Allen. Together, they have contributed to groundbreaking research that enhances the understanding and treatment of disorders linked to TNFα activity.
Conclusion: Alison J. Wilton is a prominent figure in the field of biotechnology, particularly in the development of human antibodies. Her innovative work continues to pave the way for advancements in medical research, highlighting the importance of interdisciplinary collaboration in addressing health challenges.